Literature DB >> 25305144

Polymyxin B with dual carbapenem combination therapy against carbapenemase-producing Klebsiella pneumoniae.

Nathalie Grace Chua1, Yvonne Peijun Zhou1, Thuan Tong Tan2, Pushpalatha Bangalore Lingegowda2, Winnie Lee1, Tze Peng Lim1, Jocelyn Teo1, Yiying Cai1, Andrea L Kwa3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25305144     DOI： 10.1016/j.jinf.2014.10.001

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  9 in total

1.  Double-carbapenem combination as salvage therapy for untreatable infections by KPC-2-producing Klebsiella pneumoniae.

Authors:  M Souli; I Karaiskos; A Masgala; L Galani; E Barmpouti; H Giamarellou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-02-16       Impact factor: 3.267

Review 2.  Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.

Authors:  Jesús Rodríguez-Baño; Belén Gutiérrez-Gutiérrez; Isabel Machuca; Alvaro Pascual
Journal:  Clin Microbiol Rev       Date:  2018-02-14       Impact factor: 26.132

3.  Successful Treatment of Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae Bacteremia.

Authors:  Jose F Camargo; Jacques Simkins; Thiago Beduschi; Akin Tekin; Laura Aragon; Armando Pérez-Cardona; Clara E Prado; Michele I Morris; Lilian M Abbo; Rafael Cantón
Journal:  Antimicrob Agents Chemother       Date:  2015-10       Impact factor: 5.191

Review 4.  Combination therapy for carbapenem-resistant Enterobacteriaceae: increasing evidence, unanswered questions, potential solutions.

Authors:  L E B Nabarro; B Veeraraghavan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-12       Impact factor: 3.267

Review 5.  Triple combination antibiotic therapy for carbapenemase-producing Klebsiella pneumoniae: a systematic review.

Authors:  David M Jacobs; M Courtney Safir; Dennis Huang; Faisal Minhaj; Adam Parker; Gauri G Rao
Journal:  Ann Clin Microbiol Antimicrob       Date:  2017-11-25       Impact factor: 3.944

6.  In vitro Bactericidal Activities of Combination Antibiotic Therapies Against Carbapenem-Resistant Klebsiella pneumoniae With Different Carbapenemases and Sequence Types.

Authors:  Jocelyn Qi-Min Teo; Nazira Fauzi; Jayden Jun-Yuan Ho; Si Hui Tan; Shannon Jing-Yi Lee; Tze Peng Lim; Yiying Cai; Hong Yi Chang; Nurhayati Mohamed Yusoff; James Heng-Chiak Sim; Thuan Tong Tan; Rick Twee-Hee Ong; Andrea Lay-Hoon Kwa
Journal:  Front Microbiol       Date:  2021-12-13       Impact factor: 5.640

Review 7.  Infectious disease: how to manage Gram-positive and Gram-negative pathogen conundrums with dual beta-lactam therapy.

Authors:  Alireza FakhriRavari; Brenda Simiyu; Taylor Morrisette; Yewande Dayo; Jacinda C Abdul-Mutakabbir
Journal:  Drugs Context       Date:  2022-01-20

8.  Optimizing Polymyxin Combinations Against Resistant Gram-Negative Bacteria.

Authors:  Phillip J Bergen; Zackery P Bulman; Cornelia B Landersdorfer; Nicholas Smith; Justin R Lenhard; Jürgen B Bulitta; Roger L Nation; Jian Li; Brian T Tsuji
Journal:  Infect Dis Ther       Date:  2015-12-08

Review 9.  Antimicrobials Functioning through ROS-Mediated Mechanisms: Current Insights.

Authors:  Ankita Vaishampayan; Elisabeth Grohmann
Journal:  Microorganisms       Date:  2021-12-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.